EFTA02403295

From: Masha Drokova Sent: Wednesday, Novem er , : To: Jeffrey E. I'm looking to invest at the company doing Al=based glucose monitoring system for people with diabetes. We made tec= evaluation, talked to a few experts and more a question about the market a=d regulations. Likely no, because it's complex area, but still thinki=g of them. May be someone in your network who knows this area and c=n advise on this kind of tech? Center Health =div dass="" style="font-weight: normal;">Our memo: Pros — Existing glucometers from big companies are very old-f=shioned and outdated, those companies make their revenue from overpriced st=ips — Direct compet=tors, such as iHealth and Dario have negative customer reviews a=d minor — Uses FDA-approved circuits t= get the approval in an automated manner Cons =94 Enormous pressure both from the industry players and companies such as A=ple and Google that try to develop non-invasive glucose monitoring that wit= wipe out test strip products — Young t=am = EFTA_R1_01441923 EFTA02403295